Aptamers Market is estimated to be US$ 26.6 Billion by 2034 with a CAGR of 24.7% during the forecast period

Published Date: March 2024

The report "Aptamers Market, By Type (Nucleic Acid and Peptides (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), By Application (Diagnostics, Therapeutics, and Research and Development), and Region - Global Forecast to 2034"

Aptamers Market is projected to grow from US$ 205.40 million in 2020 to US$ 985.44 million by 2030. Advancements in aptamer development technologies, increasing R&D expenditure, and the rising number of companies investing in this market are the major key driving factors responsible for the growth of global aptamers market. Low cost and high efficacy in binding to large molecules compared to antibodies and the patent expiration of systemic evolution of ligands by exponential enrichment technology (SELEX) which boosts the global market positively.

Aptamers Market was valued at US$ 2.9 Billion in 2024 and is projected to grow at a CAGR of 24.7% to reach US$ 26.6 Billion by 2034.

Key Highlights:

  • In September 2018, Base Pair Biotechnologies was awarded for discovering aptamers to canine oncology biomarkers.
  • In April 2019, Agilent and Somalogic sign agreement for supply of customized microarrays

Key Market Insights from the report:          

Aptamers Market was valued at US$ 2.9 Billion in 2024 and is projected to grow at a CAGR of 24.7% to reach US$ 26.6 Billion by 2034.over the forecast period. The market report has been segmented on the type, application, and region.

  • By type, the aptamers market is segmented into nucleic acid and peptides. The peptides is further segmented into DNA-based aptamer, RNA-based aptamers, and XNA-based aptamers.
  • By application, the aptamers market is categorized into diagnostics, therapeutics and research and development.
  • By region, North America is projected to lead the global aptamers market and is expected to remain dominant, due to rapid technological advancements and high investment and funding to support the development of aptamers.  

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Aptamers market”, By Type (Nucleic Acid and Peptides (DNA-Based Aptamers, RNA-Based Aptamers, XNA-Based Aptamers), By Application (Diagnostics, Therapeutics, and Research and Development), and by Region – forecast till 2034

The prominent player operating in the global aptamers market includes Somalogic, Inc., Noxxan Pharma AG, Aptamer Science Inc., Aptagen, Inc, AM Biotechnologies LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., TriLink BioTechnologies, Inc.

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- [email protected]

Website- www.prophecymarketinsights.com

Buy Now
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Custmoized Your Report
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request for Discount
Reliability and Reputation

Quick contact

IND: +91 777 504 9802
US: +1 860 531 2574

Trusted By

Created billion dollars of revenue impact with more than 200+ clients

View All Our Clients